Alpha 2.0
Login Register
» Articles » PMID: 38939474

Composite to Clarity: Shifting From Combined to Individual Endpoints in Meta-Analyses of Cardiovascular Outcome Trials

Overview
Journal JACC Adv
Specialty Cardiology & Vascular Diseases
Date 2024 Jun 28
PMID 38939474
Authors
Safi U Khan
Affiliations
Soon will be listed here.
Citing Articles

Clinical Efficacy and Safety of Reduced-Dose Prasugrel After Percutaneous Coronary Intervention for Taiwanese Patients with Acute Coronary Syndromes.

Chang H, Hung C, Chen Y, Fang C J Clin Med. 2024; 13(23).

PMID: 39685679 PMC: 11642127. DOI: 10.3390/jcm13237221.

References
1.
Montori V, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse J, Pacheco-Huergo V, Bryant D . Validity of composite end points in clinical trials. BMJ. 2005; 330(7491):594-6. PMC: 554039. DOI: 10.1136/bmj.330.7491.594. View
2.
Ferreira-Gonzalez I, Busse J, Heels-Ansdell D, Montori V, Akl E, Bryant D . Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ. 2007; 334(7597):786. PMC: 1852019. DOI: 10.1136/bmj.39136.682083.AE. View
3.
Zhang Y, Alonso Coello P, Brozek J, Wiercioch W, Etxeandia-Ikobaltzeta I, Akl E . Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017; 15(1):52. PMC: 5412036. DOI: 10.1186/s12955-017-0621-0. View
4.
Armstrong P, Westerhout C . Composite End Points in Clinical Research: A Time for Reappraisal. Circulation. 2017; 135(23):2299-2307. DOI: 10.1161/CIRCULATIONAHA.117.026229. View
5.
Navarese E, Lansky A, Kereiakes D, Kubica J, Gurbel P, Gorog D . Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. Eur Heart J. 2021; 42(45):4638-4651. PMC: 8669551. DOI: 10.1093/eurheartj/ehab246. View